semaglutide after tirzepatide vs Switching Semaglutide to Tirzepatide |

A large-scale genome-wide association study published in Nature in April 2026, conducted by 23andMe researchers using data from 27,885 GLP-1 medication users, identified a specific variant in the GLP1R gene the gene that encodes the primary receptor these drugs target associated with differential weight loss efficacy

Not on five-panel screens

Acetaminophen may be preferred for pain relief in patients with stomach sensitivity or kidney risk, but medical advice remains important

He stated, Semaglutide 2.4 mg not only reduces the first event risk but also lowers the cumulative cardiovascular burden making it a foundational therapy for secondary prevention in obesity-related cardiovascular disease Vince Lamanna, President of Novo Nordisk Canada, commented that these results expand the meaning of cardiovascular care by integrating obesity treatment as a proven strategy to prevent future events. He highlighted that Health Canadas decision to approve semaglutide 2.4 mg for patients with established CVD and overweight or obesity was the first global regulatory recognition of obesity therapy as a cardiovascular indication

SGLT2 inhibitors, increasingly used alongside GLP-1 therapy, can affect fluid balance and may require coordination

Your weight loss goals should be part of a comprehensive plan that includes diet, exercise, and behavioral changes, with support from your team